Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Alberter B"'
Autor:
Asperger, H., Cieslik, J.-P., Alberter, B., Köstler, C., Polzer, B., Müller, V., Pantel, K., Riethdorf, S., Koch, A., Hartkopf, A., Wiesmüller, L., Janni, W., Schochter, F., Franken, A., Niederacher, D., Fehm, T., Neubauer, H.
Publikováno v:
In Translational Oncology August 2021 14(8)
Autor:
Köstler C; Cellular and Molecular Diagnostics Group, Division of Personalized Cancer Therapy, Fraunhofer Institute of Toxicology and Experimental Medicine ITEM-R, Regensburg, Germany. caecilia.koestler@item.fraunhofer.de., Polzer B; Cellular and Molecular Diagnostics Group, Division of Personalized Cancer Therapy, Fraunhofer Institute of Toxicology and Experimental Medicine ITEM-R, Regensburg, Germany., Alberter B; Cellular and Molecular Diagnostics Group, Division of Personalized Cancer Therapy, Fraunhofer Institute of Toxicology and Experimental Medicine ITEM-R, Regensburg, Germany.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2752, pp. 11-42.
Autor:
Krapp, S., Schuy, C., Greiner, E., Stephan, I., Alberter, B., Funk, C., Marschall, M., Wege, C., Bailer, S., Kleinow, T., Krenz, B.
Geminiviral single-stranded circular DNA genomes replicate in nuclei so that the progeny DNA has to cross both the nuclear envelope and the plasmodesmata for systemic spread within plant tissues. For intra- and intercellular transport, two proteins a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::255a43552856a7bd47f659fd29abc3c4
https://publica.fraunhofer.de/handle/publica/254634
https://publica.fraunhofer.de/handle/publica/254634
Autor:
Fabisiewicz, Anna1 (AUTHOR) anna.fabisiewicz@nio.gov.pl, Szostakowska-Rodzos, Malgorzata1 (AUTHOR), Grzybowska, Ewa A.1 (AUTHOR) ewa.grzybowska@nio.gov.pl
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10612. 17p.
Autor:
Alberter, B., Polzer, B.
Die hier vorgestellte methodische Übersicht zur Charakterisierung zirkulierender oder disseminierter Zellen zeigt die Chancen und Möglichkeiten der Einzelzellanalyse bei Krebserkrankungen auf. Von der Isolation, über die Amplifikation der DNA bis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::4433ba5e28867daeaa609359c66e4835
https://publica.fraunhofer.de/handle/publica/245301
https://publica.fraunhofer.de/handle/publica/245301
Autor:
Schochter F; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany., Werner K; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany., Köstler C; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, 93053 Regensburg, Germany., Faul A; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany., Tzschaschel M; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany., Alberter B; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, 93053 Regensburg, Germany., Müller V; Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Neubauer H; Department of Obstetrics and Gynecology, University of Duesseldorf, 40225 Duesseldorf, Germany., Fehm T; Department of Obstetrics and Gynecology, University of Duesseldorf, 40225 Duesseldorf, Germany., Friedl TWP; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany., Polzer B; Division of Personalized Tumor Therapy, Fraunhofer-Institute for Toxicology and Experimental Medicine, 93053 Regensburg, Germany., Janni W; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany., Rack B; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany., Wiesmüller L; Department of Obstetrics and Gynecology, Ulm University, 89075 Ulm, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Apr 09; Vol. 12 (4). Date of Electronic Publication: 2020 Apr 09.
Autor:
Franken A; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Honisch E; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Reinhardt F; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Meier-Stiegen F; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Yang L; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Jaschinski S; Institute of Pathology, University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Duesseldorf, Germany., Esposito I; Institute of Pathology, University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Duesseldorf, Germany., Alberter B; Division of 'Personalized Tumor Therapy', Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Polzer B; Division of 'Personalized Tumor Therapy', Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany., Huebner H; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany., Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany., Pancholi S; Breast Cancer Now Toby Robins Research Centre, London, United Kingdom., Martin LA; Breast Cancer Now Toby Robins Research Centre, London, United Kingdom., Ruckhaeberle E; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Schochter F; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Tzschaschel M; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Hartkopf AD; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany., Mueller V; Department of Gynecology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Niederacher D; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Fehm T; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany., Neubauer H; Department of Obstetrics and Gynecology University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Germany. Electronic address: hans.neubauer@med.uni-duesseldorf.de.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2020 Jan; Vol. 22 (1), pp. 111-121. Date of Electronic Publication: 2019 Oct 24.
Autor:
Vigliotta, Ilaria1 (AUTHOR) ilaria.vigliotta@aosp.bo.it, Solli, Vincenza2 (AUTHOR), Armuzzi, Silvia2 (AUTHOR), Martello, Marina2 (AUTHOR), Poletti, Andrea2 (AUTHOR), Taurisano, Barbara2 (AUTHOR), Pistis, Ignazia1 (AUTHOR), Mazzocchetti, Gaia2 (AUTHOR), Borsi, Enrica1 (AUTHOR), Pantani, Lucia1 (AUTHOR), Marzocchi, Giulia2 (AUTHOR), Testoni, Nicoletta1,2 (AUTHOR), Zamagni, Elena1,2 (AUTHOR), Terracciano, Mario3 (AUTHOR), Tononi, Paola3 (AUTHOR), Garonzi, Marianna3 (AUTHOR), Ferrarini, Alberto3 (AUTHOR), Manaresi, Nicolò3 (AUTHOR), Cavo, Michele1,2 (AUTHOR), Terragna, Carolina1 (AUTHOR)
Publikováno v:
Cancers. Sep2024, Vol. 16 Issue 17, p2929. 22p.
Autor:
Weidele K; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany., Stojanović N; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany., Feliciello G; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany., Markiewicz A; Experimental Medicine and Therapy Research, University of Regensburg, 93053, Regensburg, Germany., Scheitler S; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany., Alberter B; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany., Renner P; Department of Surgery, University Medical Center, 93053, Regensburg, Germany., Haferkamp S; Department of Dermatology, University Hospital Regensburg, 93053, Regensburg, Germany., Klein CA; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.; Experimental Medicine and Therapy Research, University of Regensburg, 93053, Regensburg, Germany., Polzer B; Division of Personalized Tumour Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053, Regensburg, Germany.
Publikováno v:
International journal of cancer [Int J Cancer] 2019 Jul 01; Vol. 145 (1), pp. 232-241. Date of Electronic Publication: 2019 Jan 14.
Autor:
Stojanovic, N., Weidele, K., Scheitler, S., Alberter, B., Raab, M., Markiewicz, A., Haferkamp, S., Klein, C.A., Polzer, B.
Publikováno v:
In European Journal of Cancer July 2016 61 Supplement 1:S202-S203